Anant Pharmacs Private Limited - Company Profile

It is a business services private limited company based in Indore, Madhya Pradesh, India, established in 2024.
2024 Indore, Madhya Pradesh, India Active
Last Updated:
Access Report
About Anant Pharmacs Private Limited

Anant Pharmacs Private Limited, a active private limited company, was established on 10 May 2024 in Indore, Madhya Pradesh, India. it holds CIN: U28290MP2024PTC071189. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Amit Jain (Director), Abhijeet Jain (Director), Abhishek Jain (Director). Its latest AGM occurred on 10 November 2025, with the balance sheet filed on 31 March 2025. It is based at Flat #302, Anu Apartment, 21, 22 Shankar Nagar, Indore, Madhya Pradesh, 452018.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U28290MP2024PTC071189

  • Registration Number

    071189

  • Incorporation Date

    10 May 2024

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 9 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Anant Pharmacs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Anant Pharmacs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Anant Pharmacs Private Limited?
Current Directors
Name Designation Appointment Date Status
Amit Jain Director 10 May 2024 Current
Abhijeet Jain Director 10 May 2024 Current
Abhishek Jain Director 10 May 2024 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Anant Pharmacs.

Enhance accessibility to Anant Pharmacs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Anant Pharmacs revenue growth over time
Anant Pharmacs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Anant Pharmacs?

Unlock access to Anant Pharmacs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Anant Pharmacs?

Unlock and access historical data on people associated with Anant Pharmacs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Anant Pharmacs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anant Pharmacs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Anant Pharmacs
Recent Activity within the Organization
  • Annual General Meeting

    Anant Pharmacs Private Limited last Annual general meeting of members was held on 10 Nov 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Anant Pharmacs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was completed.

  • Director Appointment

    The activity Amit Jain was appointed as a Director was appointed as a Director on 10 May 2024 & has been associated with this company since 1 year 9 months . was completed.

  • Director Appointment

    The activity Abhijeet Jain was appointed as a Director was appointed as a Director on 10 May 2024 & has been associated with this company since 1 year 9 months . was completed.

  • Director Appointment

    Abhishek Jain was appointed as a Director was appointed as a Director on 10 May 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.

  • Company Incorporation

    Anant Pharmacs Private Limited was registered on 10 May 2024 with Roc Gwalior & aged 1 year 9 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Anant Pharmacs Private Limited?

The CIN of Anant Pharmacs Private Limited is U28290MP2024PTC071189.

Where is Anant Pharmacs Private Limited headquartered?

Anant Pharmacs Private Limited is headquartered at Flat #302, Anu Apartment, 21, 22 Shankar Nagar, Indore, Madhya Pradesh, 452018.

When was Anant Pharmacs Private Limited incorporated?

Anant Pharmacs Private Limited was incorporated on 10 May 2024.

Who are the current directors of Anant Pharmacs Private Limited?

The current directors of Anant Pharmacs Private Limited are

Is Anant Pharmacs Private Limited a listed company?

Anant Pharmacs Private Limited is unlisted.

What is the capital structure of Anant Pharmacs Private Limited?

The authorized capital of Anant Pharmacs Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available